Prime Medicine Inc — Cash Flow (NASDAQ:PRME) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities 131.83 M165.41 M122.86 M 109.06 M Cash from investing activities 47.1 M18.71 M68.46 M 185.35 M Cash from financing activities 181.49 M655 K195.88 M 150.95 M Free cash flow 115.73 M156.69 M115.57 M 103.03 M

Haberler

Vanda Pharmaceuticals (VNDA) Reports Q4 Loss, Lags Revenue Estimates

Prime Drink Group özel yerleşim işleminin ilk kapanışını tamamladı

Prime Drink Group completes first closing of private placement

Prime: Maintaining "Buy" On Solidified Catalysts For Wilson's Disease And Beyond

Prime Drink Group 5 milyon dolara kadar fon toplamak için özel yerleşim duyurdu

Prime Drink Group announces private placement to raise up to $5 million

Goldman Sachs, Prime Medicine hissesi için Erken Aşama Biyoteknoloji notunu yineledi

Goldman Sachs reiterates Early-Stage Biotech rating on Prime Medicine stock

Prime Medicine, Inc. (PRME) Reports Q3 Loss, Lags Revenue Estimates

Prime Medicine appoints Matthew Hawryluk as chief business officer

NovoCure (NVCR) Reports Q3 Loss, Tops Revenue Estimates

Prime Medicine Momentum Amid Pipeline Progress: Why I Choose To 'Hold' For Now (PRME)